Involved children in polivy's clinical studies?

Short answer: Polivy (polatuzumab vedotin) has been studied and approved mainly in adults. Its approved labeling does not include pediatric data, and safety/efficacy in children has not been established. There are no widely cited, approved pediatric indications for Polivy.

What that implies:
- No pediatric indication: Polivy is not approved for use in children.
- Pediatric involvement: If any pediatric studies exist, they have not supported a labeled pediatric indication, or they are not part of the main regulatory approvals. The main clinical program and approvals have focused on adults with B-cell lymphomas.

If you want, I can look up specific sources (FDA labeling, EU labeling, or ClinicalTrials.gov records) to confirm any pediatric trials or to identify any niche studies. Tell me if you want me to search for exact trial numbers or regulatory documents.